Emma Hall

20PUBLICATIONS
153CO-AUTHORS
Predictive and prognostic markersCardiovascular medicine and haematology not elsewhere classifiedMolecular targetsRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Sep 26, 2026
A plasma derived hypoxia signature predicts benefit from hypoxia-modifying radiotherapy and reveals dynamic humoral immune modulation in bladder cancer.

|Jan 23, 2026
Influence of Comorbidity on Endovascular Thrombectomy Outcomes for Medium-Vessel Occlusion Stroke: A Nationwide Prospective Observational Study.

Emma Hall, Johan Wassélius, Mats Pihlsgård

|Mar 04, 2025
Summary from the NCI clinical trials planning meeting on next generation of clinical trials in non-muscle invasive bladder cancer.

Andrea Apolo, Brian C Baumann, Hikmat Al-Ahmadie

|Feb 13, 2024
Improved Disease-Free Survival With Adjuvant Chemotherapy After Nephroureterectomy for Upper Tract Urothelial Cancer: Final Results of the POUT Trial.

Alison Jane Birtle, Robert Jones, John Chester

|Jul 18, 2023
International Society of Urological Pathology (ISUP) Gleason Grade Groups stratify outcomes in the CHHiP Phase 3 prostate radiotherapy trial.

David Dearnaley, Clare L Griffin, Pedro Silva

|Feb 25, 2023
The Association between Acute and Late Genitourinary and Gastrointestinal Toxicities: An Analysis of the PACE B Study.

Ragu Ratnakumaran, Victoria Hinder, Douglas Brand

Pageof 4

Frequent Collaborators

3 joint publications

Ruth Ruddle

2 joint publications

Stephen J Pettitt

2 joint publications

Bristi Basu

2 joint publications

Susana Miranda